Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int Heart J ; 64(4): 783-788, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37518359

RESUMO

Multisystem inflammatory syndrome in children (MIS-C) is a novel hyperinflammatory syndrome that is associated with severe acute respiratory syndrome coronavirus 2 infections. Reports describing the mechanical circulatory support (MCS) and myocardial biopsy for fulminant myocarditis due to MIS-C are limited.A 13-year-old male patient with MIS-C underwent treatment, including immunosuppressive therapy and MCS devices, and managed to recover from pulseless electrical activity cardiac arrest.This is the first patient in Japan with MIS-C who required MCS devices in Japan. Appropriate and immediate treatment with immunosuppressive therapy and MCS devices is important.


Assuntos
COVID-19 , Parada Cardíaca , Miocardite , Criança , Masculino , Humanos , Adolescente , COVID-19/complicações , Miocardite/complicações , Miocardite/diagnóstico , Japão , Síndrome de Resposta Inflamatória Sistêmica/diagnóstico , Síndrome de Resposta Inflamatória Sistêmica/etiologia , Síndrome de Resposta Inflamatória Sistêmica/terapia , Parada Cardíaca/complicações
2.
Int J Hematol ; 107(1): 112-116, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28597369

RESUMO

We describe an 8-year-old boy with acquired hemophilia A (AHA) associated with streptococcal infection and amoxicillin. Laboratory data revealed low factor VIII activity (FVIII:C, 1.5 IU/dl), and FVIII inhibitor (15.9 BU/ml). Comprehensive coagulation function assays, including rotation thromboelastometry (ROTEM®), revealed a markedly prolonged clotting time. Thrombin and plasmin generation (TG/PG) appeared to be moderately impaired. The inhibitor epitope of his anti-FVIII autoantibody recognized light and heavy chains. He was treated with Novoseven® and prednisolone, resulting in rapid improvement. ROTEM showed the return of coagulation time to normal level on day 20, and TG gradually improved. PG was moderately reduced in the clinical early phase, but improved at day 20. The patient's IgG subtype was IgG4 at onset. IgG1 was transiently positive on day 20, but negative on day 46. FVIII inhibitor gradually decreased and was completely absent after day 46, along with the elevated FVIII:C. IgG4 was again elevated on day 83, followed by a rapid decrease, indicative of the presence of non-neutralizing antibody, which remains currently undetected. We for the first time report changes in comprehensive coagulation function and IgG subtype of anti-FVIII antibody in a rare pediatric case of AHA.


Assuntos
Amoxicilina/efeitos adversos , Amoxicilina/uso terapêutico , Autoanticorpos/sangue , Coagulação Sanguínea , Fator VIII/imunologia , Hemofilia A/complicações , Hemofilia A/diagnóstico , Imunoglobulina G/sangue , Monitorização Fisiológica , Infecções Estreptocócicas/complicações , Infecções Estreptocócicas/tratamento farmacológico , Biomarcadores/sangue , Criança , Quimioterapia Combinada , Fator VIII/antagonistas & inibidores , Fator VIIa/uso terapêutico , Hemofilia A/sangue , Hemofilia A/tratamento farmacológico , Humanos , Masculino , Prednisolona/uso terapêutico , Proteínas Recombinantes/uso terapêutico , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...